GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaLundensis AB (XSAT:PHAL) » Definitions » Price-to-Tangible-Book

PharmaLundensis AB (XSAT:PHAL) Price-to-Tangible-Book : (As of Jun. 11, 2024)


View and export this data going back to 2010. Start your Free Trial

What is PharmaLundensis AB Price-to-Tangible-Book?

As of today (2024-06-11), PharmaLundensis AB's share price is kr0.64. PharmaLundensis AB's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was kr-0.13. Hence, PharmaLundensis AB's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for PharmaLundensis AB's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, PharmaLundensis AB's highest Price to Tangible Book Ratio was 104.70. The lowest was 10.34. And the median was 27.89.

XSAT:PHAL's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.79
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, PharmaLundensis AB's share price is kr0.64. PharmaLundensis AB's Book Value per Sharefor the quarter that ended in Mar. 2024 was kr0.05. Hence, PharmaLundensis AB's P/B Ratio of today is 12.80.


PharmaLundensis AB Price-to-Tangible-Book Historical Data

The historical data trend for PharmaLundensis AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaLundensis AB Price-to-Tangible-Book Chart

PharmaLundensis AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PharmaLundensis AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PharmaLundensis AB's Price-to-Tangible-Book

For the Biotechnology subindustry, PharmaLundensis AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaLundensis AB's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaLundensis AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where PharmaLundensis AB's Price-to-Tangible-Book falls into.



PharmaLundensis AB Price-to-Tangible-Book Calculation

PharmaLundensis AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=0.64/-0.126
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


PharmaLundensis AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of PharmaLundensis AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaLundensis AB (XSAT:PHAL) Business Description

Traded in Other Exchanges
N/A
Address
Medicon Village, Scheelevagen 2, Lund, SWE, 22381
PharmaLundensis AB is a Sweden based drug manufacturing company, The company focuses on the development and marketing of pharmaceuticals. It is engaged in developing drugs for the lung diseases, such as chronic obstructive pulmonary disease and asthma, as well as drugs for mercury toxicology.

PharmaLundensis AB (XSAT:PHAL) Headlines

No Headlines